Avalon CEO John Schneider, Ph.D. presented at BMO Capital Markets’ “The Year Ahead in Healthcare: Products, Payment and Politics” on December 15, 2015. The day-long symposium was focused on markets for life science products and featured presentations from industry leaders, including Boston Scientific, Medtronic, Abbott and Pfizer. Schneider delivered a lunchtime presentation on the medical device and biopharma industries, focusing on payment mechanisms (such as bundled payments) and the need for manufacturers to develop clear and convincing economic evidence (such as cost effectiveness models, budget impact models, and other forms of comparative effectiveness research).
